|
|
12 Health Care Stocks Moving In Monday's Pre-Market Session
|
|
|
|
Gilead Sciences Announced Definitive Agreement To Acquire Arcellx For $115 Per Share In Cash And $5 Per Share Contingent Value Right
|
|
|
|
Needham Reiterates Buy on Arcellx, Maintains $105 Price Target
|
|